Body's Cell Messaging Packets Show Promise as Foundation for Next-Generation Medicines

Researchers at the Blood and Tissue Bank are investigating extracellular vesicles (EVs)—tiny nanoparticles that cells naturally release to communicate with one another—as a revolutionary basis for future therapies. These biological packages carry essential information and perform critical functions including tissue regeneration and inflammation control. Unlike current advanced therapies that modify immune cells, genes, and tissues to treat diseases like cancer, this emerging field focuses on harnessing EVs' natural communication abilities. This approach represents a significant shift in therapeutic development and could lead to more effective treatments for multiple diseases by working with the body's own cellular messaging system.